BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 17072334)

  • 1. Inhibitors of NF-kappaB signaling: 785 and counting.
    Gilmore TD; Herscovitch M
    Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
    Epinat JC; Gilmore TD
    Oncogene; 1999 Nov; 18(49):6896-909. PubMed ID: 10602465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic protein complexes regulate NF-kappaB signaling.
    Wegener E; Krappmann D
    Handb Exp Pharmacol; 2008; (186):237-59. PubMed ID: 18491055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
    Schmid JA; Birbach A
    Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
    Yates LL; Górecki DC
    Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
    Egan LJ; Toruner M
    Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A beginner's guide to NF-kappaB signaling pathways.
    Delhalle S; Blasius R; Dicato M; Diederich M
    Ann N Y Acad Sci; 2004 Dec; 1030():1-13. PubMed ID: 15659775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-kappaB as a therapeutic target in chronic lymphocytic leukemia.
    Lopez-Guerra M; Colomer D
    Expert Opin Ther Targets; 2010 Mar; 14(3):275-88. PubMed ID: 20148715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral strategies in modulation of NF-kappaB activity.
    Lisowska K; Witkowski JM
    Arch Immunol Ther Exp (Warsz); 2003; 51(6):367-75. PubMed ID: 14692658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
    Sarkar FH; Li Y; Wang Z; Kong D
    Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting role of regulatory factors in NF-kappaB pathway with siRNA.
    Guo J; Fu YC; Becerra CR
    Acta Pharmacol Sin; 2005 Jul; 26(7):780-8. PubMed ID: 15960883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB and IKK as therapeutic targets in cancer.
    Kim HJ; Hawke N; Baldwin AS
    Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the NF-kappaB signaling pathway: implications for human disease.
    Courtois G; Gilmore TD
    Oncogene; 2006 Oct; 25(51):6831-43. PubMed ID: 17072331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
    Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
    J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
    Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Rel/NF-κB inhibitors: structural basis for mechanism of action.
    Ouk S; Liou ML; Liou HC
    Future Med Chem; 2009 Dec; 1(9):1683-707. PubMed ID: 21425986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
    Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.